ebomi
Colour theme
Sign in
Insider · CIK 0001313516

Jorden David Emerson

CIK 0001313516 Name as filed on the most recent filing

Filed as Jorden David Emerson (111)

133 transaction lines · from 111 filings · filed 2008-10-01 to 2025-12-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

133 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2011-02-09 P, Open-market purchase Cytomedix IncCMXI 4,500, acquired Open Form 4 filing 0001144204-11-006958
2011-02-04 P, Open-market purchase Cytomedix IncCMXI 6,750, acquired Open Form 4 filing 0001144204-11-006126
2011-01-25 P, Open-market purchase Cytomedix IncGTF 8,160, acquired Open Form 4 filing 0001144204-11-003990
2011-01-24 P, Open-market purchase Cytomedix IncGTF 24,440, acquired Open Form 4 filing 0001144204-11-003685
2010-12-27 P, Open-market purchase Cytomedix IncGTF 5,875, acquired Open Form 4 filing 0001144204-10-068438
2010-12-22 P, Open-market purchase Cytomedix IncGTF 5,750, acquired Open Form 4 filing 0001144204-10-067973
2010-12-21 P, Open-market purchase Cytomedix IncGTF 9,900, acquired Open Form 4 filing 0001144204-10-067727
2010-12-17 P, Open-market purchase Cytomedix IncGTF 12,925, acquired Open Form 4 filing 0001144204-10-067135
2010-12-17 P, Open-market purchase Cytomedix IncGTF 14,720, acquired Open Form 4 filing 0001144204-10-067494
2010-12-16 P, Open-market purchase Cytomedix IncGTF 6,860, acquired Open Form 4 filing 0001144204-10-066972
2010-12-15 P, Open-market purchase Cytomedix IncGTF 7,200, acquired Open Form 4 filing 0001144204-10-066636
2010-12-14 P, Open-market purchase Cytomedix IncGTF 7,285, acquired Open Form 4 filing 0001144204-10-066488
2010-12-10 P, Open-market purchase Cytomedix IncGTF 7,776, acquired Open Form 4 filing 0001144204-10-065870
2010-12-08 P, Open-market purchase Cytomedix IncGTF 10,426, acquired Open Form 4 filing 0001144204-10-065424
2010-12-07 P, Open-market purchase Cytomedix IncGTF 12,624, acquired Open Form 4 filing 0001144204-10-065232
2010-12-06 P, Open-market purchase Cytomedix IncGTF 10,456, acquired Open Form 4 filing 0001144204-10-065095
2010-12-03 P, Open-market purchase Cytomedix IncGTF 34,618, acquired Open Form 4 filing 0001144204-10-064893
2010-12-02 P, Open-market purchase Cytomedix IncGTF 17,384, acquired Open Form 4 filing 0001144204-10-064659
2010-12-01 P, Open-market purchase Cytomedix IncGTF 20,700, acquired Open Form 4 filing 0001144204-10-064441
2010-11-30 P, Open-market purchase Cytomedix IncGTF 20,999, acquired Open Form 4 filing 0001144204-10-064211
2010-11-29 P, Open-market purchase Cytomedix IncGTF 22,545, acquired Open Form 4 filing 0001144204-10-063988
2010-11-24 P, Open-market purchase Cytomedix IncGTF 5,750, acquired Open Form 4 filing 0001144204-10-063609
2010-11-23 P, Open-market purchase Cytomedix IncGTF 11,632, acquired Open Form 4 filing 0001144204-10-063430
2010-11-22 P, Open-market purchase Cytomedix IncGTF 7,200, acquired Open Form 4 filing 0001144204-10-063096
2010-11-19 P, Open-market purchase Cytomedix IncGTF 2,450, acquired Open Form 4 filing 0001144204-10-062735
2010-11-18 P, Open-market purchase Cytomedix IncGTF 3,750, acquired Open Form 4 filing 0001144204-10-062242
2010-11-16 P, Open-market purchase Cytomedix IncGTF 4,885, acquired Open Form 4 filing 0001144204-10-061683
2010-11-15 P, Open-market purchase Cytomedix IncGTF 5,266, acquired Open Form 4 filing 0001144204-10-061272
2010-11-08 P, Open-market purchase Cytomedix IncGTF 3,750, acquired Open Form 4 filing 0001144204-10-058580
2010-11-05 P, Open-market purchase Cytomedix IncGTF 10,800, acquired Open Form 4 filing 0001144204-10-058126
2010-11-04 P, Open-market purchase Cytomedix IncGTF 9,016, acquired Open Form 4 filing 0001144204-10-058126
2010-11-01 P, Open-market purchase Cytomedix IncGTF 15,134, acquired Open Form 4 filing 0001144204-10-056900
2010-10-29 P, Open-market purchase Cytomedix IncGTF 14,241, acquired Open Form 4 filing 0001144204-10-056586
2010-10-28 P, Open-market purchase Cytomedix IncGTF 18,480, acquired Open Form 4 filing 0001144204-10-056296
2010-10-26 P, Open-market purchase Cytomedix IncGTF 15,750, acquired Open Form 4 filing 0001144204-10-055710
2010-10-25 P, Open-market purchase Cytomedix IncGTF 15,750, acquired Open Form 4 filing 0001144204-10-055464
2010-10-22 P, Open-market purchase Cytomedix IncGTF 11,890, acquired Open Form 4 filing 0001144204-10-055260
2010-10-21 P, Open-market purchase Cytomedix IncGTF 14,823, acquired Open Form 4 filing 0001144204-10-055121
2010-10-08 P, Open-market purchase Cytomedix IncGTF 59,719, acquired Open Form 4 filing 0001144204-10-053301
2010-06-11 P, Open-market purchase Opexa Therapeutics, Inc.OPXA 45,507, acquired Open Form 4 filing 0001019687-10-002300
2010-06-08 P, Open-market purchase Cytomedix IncCTF 11,088, acquired Open Form 4 filing 0001144204-10-032794
2010-05-20 P, Open-market purchase Cytomedix IncGTF 9,920, acquired Open Form 4 filing 0001144204-10-029441
2010-05-18 P, Open-market purchase Cytomedix IncGTF 129,780, acquired Open Form 4 filing 0001144204-10-028903
2010-04-29 P, Open-market purchase Cytomedix IncGTF 18,000, acquired Open Form 4 filing 0001144204-10-022898
2010-04-28 P, Open-market purchase Cytomedix IncGTF 10,080, acquired Open Form 4 filing 0001144204-10-022832
2010-04-16 P, Open-market purchase Cytomedix IncGTF 13,139, acquired Open Form 4 filing 0001144204-10-020832
2010-04-14 P, Open-market purchase Cytomedix IncGTF 18,094, acquired Open Form 4 filing 0001144204-10-020721
2010-04-13 P, Open-market purchase Cytomedix IncGTF 56,000, acquired Open Form 4 filing 0001144204-10-020725
2010-04-13 P, Open-market purchase Cytomedix IncGTF 56,000, acquired Open Form 4 filing 0001144204-10-020006
2009-12-11 P, Open-market purchase Opexa Therapeutics, Inc.OPXA 48,700, acquired Open Form 4 filing 0001157523-09-008561

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 120
  • Open-market sale 13
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. JORDEN DAVID EMERSON, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001313516

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.